Recursion Pharmaceuticals (RXRX) Notes Payables (2020 - 2024)
Recursion Pharmaceuticals (RXRX) posted Notes Payables of $55000.0 for Q1 2024, up 34.15% on a QoQ basis from $41000.0 in Q4 2023, and down 91.68% year-over-year from $661000.0 in Q2 2023.
Recursion Pharmaceuticals (RXRX) Notes Payables (2020 - 2024) Analysis & Trends
Recursion Pharmaceuticals' Notes Payables history runs 5 years deep, the most recent figure standing at $55000.0 for Q1 2024.
- Quarterly Notes Payables fell 91.68% year-over-year to $55000.0 in Q1 2024, while the trailing twelve-month figure through Mar 2024 was $55000.0 (down 91.68% YoY) and the FY2023 annual result came in at $41000.0, down 57.73% from the prior year.
- Notes Payables was $55000.0 for Q1 2024 at Recursion Pharmaceuticals, up from $41000.0 in the prior quarter.
- Across five years, Notes Payables topped out at $3.1 million in Q2 2021 and bottomed at $41000.0 in Q4 2023.
- A 5-year average of $645428.6 and a median of $96000.0 in 2022 frame the typical range for Notes Payables.
- Annual changes were most pronounced in 2022 — Notes Payables plunged 97.03% — and 2023, when it jumped 631.58%.
- Recursion Pharmaceuticals' Notes Payables stood at $1.1 million in 2020, then slumped by 91.61% to $90000.0 in 2021, then rose by 7.78% to $97000.0 in 2022, then slumped by 57.73% to $41000.0 in 2023, then surged by 34.15% to $55000.0 in 2024.
- Business Quant data shows RXRX's Notes Payables at $55000.0 in Q1 2024, $41000.0 in Q4 2023, and $695000.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Recursion Pharmaceuticals | 1.59 Bn | 933.22 Mn | -6.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 55,000.00 |
| Dec 31, 2023 | 41,000.00 |
| Sep 30, 2023 | 695,000.00 |
| Jun 30, 2023 | 676,000.00 |
| Mar 31, 2023 | 661,000.00 |
| Dec 31, 2022 | 97,000.00 |
| Sep 30, 2022 | 95,000.00 |
| Jun 30, 2022 | 93,000.00 |
| Mar 31, 2022 | 92,000.00 |
| Dec 31, 2021 | 90,000.00 |
| Sep 30, 2021 | 88,000.00 |
| Jun 30, 2021 | 3.14 Mn |
| Mar 31, 2021 | 2.15 Mn |
| Dec 31, 2020 | 1.07 Mn |